Your browser doesn't support javascript.
loading
Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
García-García, Irene; Dapía, Irene; Montserrat, Jaime; Martinez de Soto, Lucía; Bueno, David; Díaz, Lucía; Queiruga, Javier; Rodriguez Mariblanca, Amelia; Guerra-García, Pilar; Ramirez, Elena; Frías, Jesus; Pérez Martínez, Antonio; Carcas-Sansuan, Antonio J; Borobia, Alberto M.
Afiliação
  • García-García I; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Dapía I; Medical and Molecular Genetics Institute (INGEMM), La Paz University Hospital, Madrid, Spain.
  • Montserrat J; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Martinez de Soto L; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Bueno D; Paediatric Haemato-oncology Department, University Hospital La Paz, Madrid, Spain.
  • Díaz L; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Queiruga J; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Rodriguez Mariblanca A; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Guerra-García P; Paediatric Haemato-oncology Department, University Hospital La Paz, Madrid, Spain.
  • Ramirez E; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Frías J; Medical and Molecular Genetics Institute (INGEMM), La Paz University Hospital, Madrid, Spain.
  • Pérez Martínez A; Paediatric Haemato-oncology Department, University Hospital La Paz, Madrid, Spain.
  • Carcas-Sansuan AJ; Clinical Pharmacology Department, IdiPAZ, La Paz University Hospital School of Medicine, Autonomous University of Madrid, Madrid, Spain.
  • Borobia AM; Paediatric Haemato-oncology Department, University Hospital La Paz, Madrid, Spain.
Front Pharmacol ; 12: 717932, 2021.
Article em En | MEDLINE | ID: mdl-34744712
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha